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Abstract 
The study aimed to assess the level of medication adherence among psychiatric outpatients and to determine the 
main predictors associated with medication non-adherence. A cross sectional study was conducted among 298 
psychiatric outpatients at Punjab Institute of Mental Health (PIMH), Lahore, Pakistan. A designed questionnaire 
was used as data collection tool and adherence was evaluated using MARS (Medication Adherence Rating 
Scale). Data was analyzed using SPSS version 21.0. Logistic regression was applied to determine the predictors 
of non-adherence. Medication adherence rate varied from low (39.3%) to high (60.7%) adherence. The impact 
of demographic factors such as age, gender, diagnosis, employment status and comorbidity on medication 
adherence were insignificant.  
------------------------------------------------------------------------ 
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Results of chi-square found that marital status, duration of illness from last visit, patient factors, medication 
factors, disease factors were significantly associated with adherence (p<0.05). Multivariate binary logistic 
regression indicated that qualification, marital status, number of tablets per day, duration of illness from last 
visit, patient factors, disease factors were the main predictors of medication non-adherence.   
Key words: Predictors; non-adherence; psychiatry; psychotropic medication; mental disorders; outpatients. 
1. Introduction 
World Health Organization (WHO) stated that almost 450 million people suffered from a mental and behavioral 
disorders globally and 33% of all years lived with disability (YLDs) because of neuropsychiatric disorders [1]. 
In Pakistan, more than 14 million, 10-16% of population, is suffering from mild to moderate psychiatric issues 
and mental health remains the most neglected field [2]. Psychiatric illness is important concern for public health 
and adherence is the foremost component of treatment in recent years [3,4].  Medication adherence  is defined as 
“the extent to which patient’s behavior matches agreed recommendations from the prescriber”[5].WHO stated 
that in industrialized countries on average only 50% of patients with chronic ailment follows treatment 
recommendations [6]. In systematic review by Cramer, psychiatrically ill patients treated with antipsychotic 
medications have adherence in the range of 24-90%  whereas among those on antidepressants were in the range 
of 40-90% [7]. Several  patients never start taking their medicines or even stop treatment entirely within the first 
12 months and only few continue therapy as advised by their doctor[8]. Velligan found that partial adherence, 
non- adherence and provider under estimation about adherence frequently lead to excessive medication therapy, 
complex regimen and incidence of adverse drug reactions. Estimations of adherence by provider are overly 
optimistic and are the least trustworthy [9]. Moreover, pharmacists are at well position to address medication 
non adherence. A recent meta-analysis showed that interventions provided by health care teams with 
pharmacists significantly affect patient care as compared to without pharmacist interventions [10]. Medication 
non-adherence has major influence on patient recovery and can result in relapse, functional disability, re-
hospitalization and subsequently increased costs to patients and healthcare system [11,12]. According to a 
comprehensive literature survey by Cutler and his colleagues yearly cost of non-adherence on mental healthfor 
each patient ranged from $3252 to $19363. With every 25% decline in rate of adherence, non-adherence total 
cost increase incredibly[13]. Non adherence is a global challenge but still remains hidden within patient 
consultations. Patients may be hesitant in raising their concerns and troubles with their doctors, that doctors will 
misinterpret it as lack of trust in their medicines and skills. However, when patients were allowed to negotiate 
treatment therapy with their doctors, medication adherence tends to increase up to 80%, highlighting the need of 
patient involvement in course of treatment.  Therefore, a strong and trustworthy relationship between patient and 
doctor can defend against non-adherence(Chapman and Horne, 2013; Hardeman and his colleagues 2010). Risk 
factors associated with non-adherence include negative attitude, symptom severity, shorter duration of illness, 
past experience, comorbidity, substance abuse, adverse drug reaction, cultural or religious beliefs about 
medication, living alone or lack of social support [11,16,17]. Typical reasons of non-adherence are numerous 
and  include forgetfulness, felt better, decide to omit dose, lack of information, medication cost, sedation, too 
many pills and alternative medicine [4,18]. The main purpose of this study was to assess the level of medication 
adherence and to determine the main predictors associated with medicationnon-adherence among psychiatric 
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outpatients at a mental healthcare hospital of Lahore, Pakistan. 
2. Methods 
2.1 Study setting 
A hospital based cross-sectional study was conducted in psychiatric outpatient department in Punjab Institute of 
Mental Health (PIMH), Lahore. It is 1400 bedded hospital with major facilities for mentally sick patients, in 
South Asia.  PIMH was founded in 1900AD as “Lunatic Asylum” only facility to provide care to psychiatric 
patients and named into “Government Mental Hospital” and renamed as “Government Hospital for Psychiatric 
Diseases" in 1996, and was renamed as “Punjab Institute of Mental Health” in 2002.  
2.2 Study participants 
The source population comprised of all psychiatric patients visiting outpatient department in the hospital; while 
study population consisted of outpatients who were on treatment and receiving psychotropic drugs for at least 
one month with age of 18 years or above, mentally stable, able to understand the nature of study and gave 
consent. Inpatients, patients with epilepsy, with severe mental retardation and unconsciousness or who had 
history of drug abuse were excluded from the study.  The study was conducted between 14th November 2018 
and 30th December, 2018. Sample size was calculated using the single proportion formula for the present study 
(Daniel formula, 1995):  n = Z2 P (1-P)/d2. Sample size was determined to be 298 with employing Z-score of 
1.96 with 5% degree of precision.   
2.3 Data collection and assessment 
The data was collected in specially designed questionnaire which include following details 
2.3.1 Demographic and clinical characteristics of patient 
It consisted of name, age, gender, residence, qualification, marital status, employment status, monthly income, 
diagnosis, comorbidities, duration of illness, duration of continuous therapy, duration of illness from last visit, 
number of tablets patient take per day, administration of medication and physician follow up.  
2.3.2 Medication Adherence Rating Scale (MARS) 
Patients’ medication adherence to psychotherapeutic drugs was assessed by Medication Adherence Rating Scale 
(MARS), which is highly specific for psychiatric illness. The MARS comprised of 10 items with response yes or 
no. The first 4 items are based on Medication Adherence Questionnaire MAQ and coded as no = 1 and yes = 0 
while other items are based on Drug Attitude Inventory DAI and are coded as Q5, Q6, Q9, Q10 n = 1 and yes = 
0; Q7, Q8, no=0 and yes=1. A total score will then reveal the level of adherence, scoring less than 6 is 
considered as low adherence and above 6 as high level of adherence.   
2.3.3 Factors associated with non-adherence  
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It consisted of various factors associated with non-adherence to medication questions based on 10 item scale 
with responses from a 5 point Likert scale with A=strongly disagree, B=disagree, C=neutral, D=agree, 
E=strongly agree. The items included I don’t adhere to medication because of 1) Forgetting, 2) Un-conducive 
timings of medication, 3) Cost of medicines , 4) After becoming better, 5) They have little benefit, 6) I have 
alternative medicine, 7) Little availability of medicine, 8) Bad society belief on psychiatric medicine, 9) 
Frequent travelling, 10) There are too many pills. 
2.4 Ethical approval 
Approval for this study was obtained from the Bioethics Review Committee of Quaid-i-Azam University, and 
“Punjab Institute of Mental health, Lahore”. This study was observational with no interventions. There was no 
direct or indirect hazardous risk to the patient, prescriber or the researcher. A written consent was obtained from 
patients or their attendants.    
2.5 Data analysis 
Data was managed using SPSS for Window Version 21.0”.Descriptive statistics were obtained for data 
summarization. Chi-square tests were used to determine association between categorical response i.e. adherence 
and categorical factors. Similarly independent sample t-test was used to determine the association between 
categorical response i.e. adherence and continuous factors. Principal Component Analysis (PCA), a dimension 
reduction tool, was used specifically for adherence scores computation based on several questions. Multivariate 
binary logistic regression was applied to identify the main predictors of medication non-adherence among 
psychiatric patients. The significance level for independent variables was set at 0.05 (two-tailed). 
3. Results 
3.1 Demographic and clinical characteristic of patients 
Out of 298 patients, 56.7% (169) were males, and 43.3% (129) were females. Almost half of the patients 56.7% 
(169) were rural, and 43.3% (129) were urban. About 33.9% of the patients were of age >18-29 years, 26.8% of 
30-39 years, 20.1% of 40-49 years, 9.4% of 50-59 years and 9.7% of 60->65 years. The highest number of 
patients were found in adult age (<18-29). Majority of the patients 69.5% were illiterate while only 30.5% were 
literate (21.8% had precollege education and only 8.7% were highly educated). Majority of the patients 40.3% 
(120) were diagnosed with psychotic disorders followed by 26.5% (79) patients with bipolar disorders, 24.8% 
(74) with depressive disorders, and 8.4% (25) with anxiety disorder. Only 16.4% (49) patients had some 
comorbidities while 83.9% (249) had no comorbidity. 
3.2 Measure of medication adherence 
MARS scale was used to evaluate the level of medication adherence. It is 10 item scale with response yes/no. 
Figure 1 shows the response of sample population. Most of the patients (72.5%) respond that they can prevent 
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getting sick by staying medicines, 61.0% said that medication makes them feel tired and sluggish,58.7% respond 
that they forget to take medicine and 54% said that they are careless about taking medicine. While 46.6% and 
40.9% patients stop taking medicines when they feel worse and better respectively. Scores less than 6 is marked 
as low adherence and above 6 as high adherence.Adherence response based on MARS scale states that 39.9% of 
sample population had low adherence and 60.7% had high adherence. 
 
Figure 1: Distribution of Medication Adherence Rating Scale (MARS) of sample population (n=298) 
3.3 Predictors of medication non-adherence 
Chi-square tests were used to determine association between categorical response i.e. adherence (low, high) and 
categorical factors (demographic and clinical).Similarly independent t-test was used to determine the association 
between categorical response i.e. adherence (low, high) and continuous factor (duration of illness from last 
visit). Table 1shows the significant relationship between marital status and adherence (p< 0.05).Number of 
tablets patients take per day is statistically associated with medication non-adherence (p<0.05). Duration of 
illness from last visit and medication adherence is also significant (p<0.05). Chi- square test was applied to 
factors associated with medication non-adherence mentioned in Table 1. 
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Table 1: Predictors of medication non-adherence among the study population (n=298) 
 Adherence Chi square 
p-value 
 Low n (%) High n (%)  
 n=117 n=181  
Demographic characteristics of patients 
Gender 
Male 
Female 
 
70(41.4%) 
 
99(58.6%) 
0.382 
47(36.4%) 82(63.6%) 
Residence 
Rural 
Urban 
 
70(41.4%) 
 
99(58.6%) 
0.382 
47(36.4%) 82(63.6%) 
Qualification 
Illiterate 
Literate 
 
83(40.1%) 
 
124(59.9%) 
0.656 
34(52.3%) 57(62.6%) 
Age (years) 
18-29 
30-39 
40-49 
50-59 
>60 
 
43(42.6%) 
 
58(57.4%) 
0.515 
31(38.8%) 49(61.3%) 
23(38.3%) 37(61.7%) 
7(25.0%) 21(75.0%) 
13(44.8%) 16(55.2%) 
Marital status 
Single 
Married 
Divorced/widow 
 
47(45.6%) 
 
56(54.4%) 
0.043 
63(38.9%) 99(61.1%) 
7(21.2%) 26(78.8%) 
Employment status 
Employed 
Unemployed 
 
39(41.1%) 
 
56(58.9%) 
0.665 
78(38.4%) 125(61.6%) 
Monthly income 
Less than 15000PKR 
More than 15000PKR 
 
83(38.2%) 
 
134(61.8%) 
0.558 
 
 
 
34(42.0%) 47(58.0%) 
Clinical characteristics of patients 
 
Diagnosis of patient 
Depressive disorder 
Psychotic disorder 
Bipolar disorder 
Anxiety disorder 
 
28(37.8%) 
 
46(62.2%) 
0.784 
50(41.7%) 70(58.3%) 
28(35.4%) 51(64.6%) 
11(44.0%) 14(56.0%) 
 Comorbidity 
Yes 
No 
 
17(34.7%) 
 
32(65.3%) 
0.474 
100(40.2%) 149(59.8%) 
Duration of illness 
Less than 1yr 
1-4yrs 
More than 4yrs 
 
31(34.8%) 
 
58(65.2%) 
0.575 
63(40.6%) 92(59.4%) 
23(42.6%) 31(57.4%) 
Duration of continuous therapy 
Less than 4yr 
More than 4yrs 
 
107(38.4%) 
 
172(61.6%) 
0.217 
10(52.6%) 9(47.4%) 
Number of tablets patients take per day   0.000 
1-3 tablets 16(21.6%) 58(78.4%) 
4-6 tablets 66(39.5%) 101(60.5%) 
7-9 tablets 27(56.3%) 21(43.8%) 
>10 tablets 8(88.9%) 1(11.1%) 
Administration of medication   0.558 
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Self 
Relative 
81(38.2%) 131(61.8%) 
36(41.9%) 50(58.1%) 
Physician make follow up 
Yes 
No 
 
107(39.3%) 
 
165(60.7%) 
0.930 
10(38.5%) 16(61.5%) 
Duration of illness from last visit* 2.11±1.55 1.40±0.947 0.000 
 
Factors associated with non- adherence 
Forget to take medication 
Un-conductive timing of medication 
Cost of medication 
Stop taking medication after becoming better 
Psychiatric medication have little benefits 
Use of alternative medicine 
Little availability of medicines 
Bad society belief on psychiatric 
Frequent travelling 
Too many pills 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
0.000 
0.372 
0.000 
 
0.000 
 
0.001 
0.020 
0.000 
0.000 
0.001 
*Independent t- test 
Table 2: Multivariate binary logistic regression analysis evaluating effect of demographic, clinical 
characteristics and factors on medication non-adherence 
Variables Levels B S.E. Sig. Odd 
Ratios 
Confidence 
Interval 
95% 
       
Qualification Illiterate  Reference 
Literate 0.797 0.386 0.039* 2.219 
 
1.04 - 4.72 
Marital status Single  Reference 
Married  0.528 0.370 0.153 1.695 0.82 – 3.49 
Divorced/widow 1.891 0.607 0.002* 6.626 
 
2.01 – 21.7 
Duration of illness 
from last visit 
 
 -0.252 0.131 0.05* 0.777 0.60 – 1.00 
Number of tablets 
patients take per day 
 
1-3 tablets 
 
Reference 
4-6 tablets -1.20 0.412 0.003* 0.300 0.13 - 0.67 
7-9 tablets -2.029 0.536 0.000* 0.131 0.04 - 0.37 
>10 tablets -4.198 1.238 0.001* 0.015 0.00 – 0.17 
f1(Patient factors) No  Reference 
 Yes  -1.244 0.331 0.000* 0.288 0.15 – 0.55 
f2(Medication factors) No Reference 
 Yes -0.593 .342 .083 .553 0.28 – 1.08 
f3(Disease factors) No Reference 
 Yes  -2.187 .348 .000* .112 0.57 – 0.22 
 
*p-value< 0.05; 95% confidence interval  
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Principal Component Analysis was applied to factors associated with medication non-adherence mentioned in 
Table 1. In Principal Component Analysis, 3 components were identified. The first component contained patient 
related factors (such as forgetting, un-conductive timing of medicine). Second component contained medication 
related factors (such as cost of medicines andalternative medicines) while third component contained disease 
factors (feeling better, little benefit).  Results of multivariate binary logistic regression of independent variables 
and adherence are shown in Table 2. Finding from the logistic regression indicates that qualification, marital 
status, number of tablets per day, patient factors, disease factors weremain factors associated with medication 
non-adherence.  
3. Discussion 
In present study, 39.3% (117) patients were poorly adherent with psychiatric medications. This outcome is 
consistent with non- adherence rates stated in Southwest Ethiopia, 41.2% [19]; in South Africa, 37% [20]; in 
Central Ethiopia, 41.0% [21]. However, this finding of non- adherence is much lower than rates in  Saudi 
Arabia, 74% [16]; in Egypt 74.0% [22] ; in Jordan 64.0% [22] The difference in studies might be because of 
different study population, study design,study settings, sample size, inclusion exclusion criteria, measuring scale 
used. In our study, we used MARS which is 10 item scale with response yes/no. Score less than 6 is marked as 
low adherence and above 6 as high adherence. Effect of demographic characteristics such as age, gender, 
residence, employment status, monthly income on medication adherence were insignificant (p>0.05). This 
consonants with the findings of Sanele study in South Africa [20]. In contrast to other studies, where age was 
significantly associated with medication adherence. A younger person with high risk of non-adherence implies 
that they have more negative perception towards psychiatric medications[12,23] However, qualification (p< 
0.05) and marital status (p<0.05) had significant impact on adherence. Literate individuals have more insight 
regarding adhering to medication possibility knowing the long run consequences [24,25];  People with marital 
status divorced/window were found to be statistically significant with adherence. This controversial finding 
about marital status and adherence wasalso found by study in Mekelle, Northern Ethiopia [12]. Some studies 
concluded that adherence did not differ significantly on marital status [26] and [27]. Another study noted that 
married status had significant association with poor adherence [28].  Duration of illness from last visit (P<0.05) 
and number of tablets patient take per day (P<0.05) is significantly associated with greater adherence. Patients 
who visited doctor after every one month were more adherent to their medicines as it enhances patient doctor 
relationship which is quite important and keystone for patient care thus enhancing medication adherence. In 
addition, as number of tablets increases adherence reduced drastically and higher number of medicines is more 
frequently associated non adherence.  Among different diagnosis of disease, patients suffering from anxiety 
disorder (44.0%) were the least to comply, followed by psychotic disorder (41.7%), depressive disorder and 
bipolar disorder (35.4%). Prevalence of different disorders varies from society to society. A former study shows 
that 74% of schizophrenic outpatients stop taking neuroleptics or antipsychotics within two years of leaving 
hospital and 20-25% bipolar patients are non-compliant [29] . In our study, feeling tired and sluggish (61%), 
forget to take medicine (58.7%), careless to take medicine (54%), stop taking medicine when feel worse 
(46.6%), stop taking medicine when feel better (40.9%), unnatural to be controlled by medication (28.2%) were 
the major findings according to the MARS. Moreover, considering the realization because of illiteracy and lack 
of knowledge patients stop taking medicines. This attitude is further precipitated by the sigma to 
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mentalillnesses, treatment from quacks and traditional faith healers and improper education of patients (Taj and 
Khan, 2005). Patient related factors such as forgetting (p<0.05), un-conductive timing of medicine (p<0.05), bad 
society belief on psychiatric medicine (p<0.05) and frequent travelling (p<0.05) were significantly associated 
with adherence. Forgetfulness is the foremost factor affecting medication adherence and patients stopped 
medication when feel worse are in line with many previous research [4,8,31].  Medicines related factors such as 
alternative medicine (p<0.05), little availability (p<0.05), too many pills (p<0.05) were statistically significant. 
Unlike former studies in Pakistan [4] and (Taj and Khan, 2005) , our study did not show treatment cost as the 
most common reason of non-adherence because of highly effective welfare programme and government free 
medicine facilities in our hospital.  Disease related or condition related factors such as feeling better (P>0.05) is 
significantly associated with adherence because on long term use patient have few and little symptoms which is 
a major barrier to take medicines and moreover little benefit (P>0.05) is also significant based on psychiatric 
patients negative belief that medicines are less essential. This finding coincides with study on belief about 
medicines which found that psychiatric group attained lower on the need of taking medication and non-adherent 
patients felt medication to be less necessary [32]. 
4. Limitation 
Every study has some limitations. First limitation to our study is a cross sectional study design conducted in 
only single setting hospital; although PIMH is the largest facility for psychiatrically ill patients in South Asia but 
still our findings cannot be generalized. Small sample size and use of self-reporting scale for medication 
adherence may underestimate the magnitude of the reality as there may be a response bias as concomitant with 
self-reporting. Moreover, because of cross sectional nature of the study design cause-effect relationship cannot 
be established although study is helpful to probe associations between variables. 
5. Conclusion 
Mental health remains a serious and immensely increasing dispute in Pakistan. Many of the patients had low 
adherence to psychiatric medications.Efforts should be made to improve the medication adherence. Psycho 
education and counseling should be employed to overcome the patient related factors which further improve 
medication adherence. Phone reminders and pillboxes with paging system of medication can also be employed. 
Family members or caregivers should be advised to help patients to take their medications. Pharmacist should be 
employed along with psychiatrists, as they have better knowledge in patient care, treatment assessment, 
medication management, monitoring of potential adverse drug reactions and interactions can educate patients 
and their families in much better way. 
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